FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014558162> ?p ?o ?g. }

• W2014558162 endingPage "180" @default.
• W2014558162 startingPage "175" @default.
• W2014558162 abstract "An excessive hypertrophic response of the heart to an increased workload is a leading cause of heart failure. At present, cardiac hypertrophy is treated with inhibitors of the renin–angiotensin system or with β-adrenoceptor antagonists. These current therapeutic strategies inhibit prohypertrophic signaling pathways, but this therapy is inadequate in a substantial number of patients. However, the hypertrophic response of the heart is the net result of activation of prohypertrophic and antihypertrophic pathways. Glycogen synthase kinase-3β (GSK-3β) has a powerful antihypertrophic effect, but is inhibited by growth factors and hypertrophic stimuli through phosphorylation at the Ser9 residue of GSK-3β. Activation of the Wnt/frizzled pathway also results in inactivation of GSK-3β through sequestration of the kinase rather than phosphorylation at Ser9. In this Opinion article we will review the current evidence for the involvement of Wnt/frizzled signaling and the activation of GSK-3β in the regulation of cardiac hypertrophy, and subsequently discuss the potential of this pathway to serve as a novel therapeutic approach for cardiac hypertrophy. An excessive hypertrophic response of the heart to an increased workload is a leading cause of heart failure. At present, cardiac hypertrophy is treated with inhibitors of the renin–angiotensin system or with β-adrenoceptor antagonists. These current therapeutic strategies inhibit prohypertrophic signaling pathways, but this therapy is inadequate in a substantial number of patients. However, the hypertrophic response of the heart is the net result of activation of prohypertrophic and antihypertrophic pathways. Glycogen synthase kinase-3β (GSK-3β) has a powerful antihypertrophic effect, but is inhibited by growth factors and hypertrophic stimuli through phosphorylation at the Ser9 residue of GSK-3β. Activation of the Wnt/frizzled pathway also results in inactivation of GSK-3β through sequestration of the kinase rather than phosphorylation at Ser9. In this Opinion article we will review the current evidence for the involvement of Wnt/frizzled signaling and the activation of GSK-3β in the regulation of cardiac hypertrophy, and subsequently discuss the potential of this pathway to serve as a novel therapeutic approach for cardiac hypertrophy." @default.
• W2014558162 created "2016-06-24" @default.
• W2014558162 creator A5021274371 @default.
• W2014558162 creator A5035889183 @default.
• W2014558162 creator A5073722505 @default.
• W2014558162 creator A5086196292 @default.
• W2014558162 date "2008-04-01" @default.
• W2014558162 modified "2023-10-16" @default.
• W2014558162 title "The Wnt/frizzled/GSK-3β pathway: a novel therapeutic target for cardiac hypertrophy" @default.
• W2014558162 cites W1574348020 @default.
• W2014558162 cites W1895665623 @default.
• W2014558162 cites W1976320711 @default.
• W2014558162 cites W1983712244 @default.
• W2014558162 cites W1997883674 @default.
• W2014558162 cites W2004209718 @default.
• W2014558162 cites W2008421466 @default.
• W2014558162 cites W2012919091 @default.
• W2014558162 cites W2013880106 @default.
• W2014558162 cites W2014135028 @default.
• W2014558162 cites W2015994246 @default.
• W2014558162 cites W2018842010 @default.
• W2014558162 cites W2036272929 @default.
• W2014558162 cites W2036711492 @default.
• W2014558162 cites W2037957201 @default.
• W2014558162 cites W2041043528 @default.
• W2014558162 cites W2063481915 @default.
• W2014558162 cites W2069409989 @default.
• W2014558162 cites W2071849965 @default.
• W2014558162 cites W2072392892 @default.
• W2014558162 cites W2073389709 @default.
• W2014558162 cites W2086582316 @default.
• W2014558162 cites W2102841229 @default.
• W2014558162 cites W2105953048 @default.
• W2014558162 cites W2113788146 @default.
• W2014558162 cites W2114355635 @default.
• W2014558162 cites W2119780609 @default.
• W2014558162 cites W2119787665 @default.
• W2014558162 cites W2131567644 @default.
• W2014558162 cites W2134573562 @default.
• W2014558162 cites W2139522433 @default.
• W2014558162 cites W2139855640 @default.
• W2014558162 cites W2140608810 @default.
• W2014558162 cites W2142360968 @default.
• W2014558162 cites W2144957696 @default.
• W2014558162 cites W2146261185 @default.
• W2014558162 cites W2155507705 @default.
• W2014558162 cites W2163537274 @default.
• W2014558162 cites W2170208738 @default.
• W2014558162 cites W2171515161 @default.
• W2014558162 cites W2334499091 @default.
• W2014558162 doi "https://doi.org/10.1016/j.tips.2008.01.003" @default.
• W2014558162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18342376" @default.
• W2014558162 hasPublicationYear "2008" @default.
• W2014558162 type Work @default.
• W2014558162 sameAs 2014558162 @default.
• W2014558162 citedByCount "74" @default.
• W2014558162 countsByYear W20145581622012 @default.
• W2014558162 countsByYear W20145581622013 @default.
• W2014558162 countsByYear W20145581622014 @default.
• W2014558162 countsByYear W20145581622015 @default.
• W2014558162 countsByYear W20145581622016 @default.
• W2014558162 countsByYear W20145581622017 @default.
• W2014558162 countsByYear W20145581622018 @default.
• W2014558162 countsByYear W20145581622019 @default.
• W2014558162 countsByYear W20145581622020 @default.
• W2014558162 countsByYear W20145581622021 @default.
• W2014558162 countsByYear W20145581622022 @default.
• W2014558162 countsByYear W20145581622023 @default.
• W2014558162 crossrefType "journal-article" @default.
• W2014558162 hasAuthorship W2014558162A5021274371 @default.
• W2014558162 hasAuthorship W2014558162A5035889183 @default.
• W2014558162 hasAuthorship W2014558162A5073722505 @default.
• W2014558162 hasAuthorship W2014558162A5086196292 @default.
• W2014558162 hasConcept C104629339 @default.
• W2014558162 hasConcept C107300179 @default.
• W2014558162 hasConcept C11960822 @default.
• W2014558162 hasConcept C126322002 @default.
• W2014558162 hasConcept C134018914 @default.
• W2014558162 hasConcept C137620995 @default.
• W2014558162 hasConcept C167414201 @default.
• W2014558162 hasConcept C182996813 @default.
• W2014558162 hasConcept C192118531 @default.
• W2014558162 hasConcept C2778198053 @default.
• W2014558162 hasConcept C62478195 @default.
• W2014558162 hasConcept C71924100 @default.
• W2014558162 hasConcept C86803240 @default.
• W2014558162 hasConcept C95444343 @default.
• W2014558162 hasConcept C98274493 @default.
• W2014558162 hasConceptScore W2014558162C104629339 @default.
• W2014558162 hasConceptScore W2014558162C107300179 @default.
• W2014558162 hasConceptScore W2014558162C11960822 @default.
• W2014558162 hasConceptScore W2014558162C126322002 @default.
• W2014558162 hasConceptScore W2014558162C134018914 @default.
• W2014558162 hasConceptScore W2014558162C137620995 @default.
• W2014558162 hasConceptScore W2014558162C167414201 @default.
• W2014558162 hasConceptScore W2014558162C182996813 @default.
• W2014558162 hasConceptScore W2014558162C192118531 @default.
• W2014558162 hasConceptScore W2014558162C2778198053 @default.

• next